• Profile
Close

Efficacy and safety of a new hyaluronic acid filler for nasolabial folds: A 52‐week, multicenter, randomized, evaluator/subject‐blind, split‐face study

Journal of Cosmetic Dermatology Apr 29, 2021

Cheon HI, Kim JH, Kim BJ, et al. - Researchers conducted this multicenter, randomized, evaluator/subject‐blind, active‐controlled, split‐face study to compare the effectiveness and safety between DIVAVIVA medium, a novel biphasic hyaluronic acid filler incorporating lidocaine, and Restylane Perlane Lidocaine for moderate to severe nasolabial folds. Data reported that the mean change of WSRS at week 24 was −0.61 ± 0.54 in DIVAVIVA medium group and −0.59 ± 0.49 in Restylane Perlane Lidocaine group. For the correction of moderate to severe nasolabial folds, DIVAVIVA medium has comparable efficacy and safety to Restylane Perlane Lidocaine.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay